ArticleBMC pregnancy and childbirth2025
Complications in hospitalized neonates born to mothers with HDP subtypes: a retrospective cohort study and mediation analysis.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Neonatal outcomes of hypertensive pregnancy subtypes in very preterm infants: a multicenter cohort study.BMC pediatrics · 2026Observational
- Maternal Complications Associated with Primiparous Adolescent Pregnancies.Journal of clinical medicine · 2026Article
- Prevalence of Hypertensive Disorders of Pregnancy and Associated Birth Outcomes Among Adolescent Mothers at a Tertiary Hospital in Zambia: A Retrospective Cross-Sectional Study.International journal of hypertension · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHypertensive disorders in pregnancy (HDP), including four subtypes, are common complications significantly contributing to perinatal morbidity and mortality. Research on the impact of HDP subtypes-preeclampsia/eclampsia (PE/E) and superimposed preeclampsia (SP)-on comprehensive outcomes for hospitalized neonates is relatively limited. Additionally, PE/E and SP often result in shorter gestational age (GA), and the role of GA in the preterm birth-related complications of these HDP subtypes remains unclear.
methodsThis retrospective cohort study identified a total of 989 cases (exposed group), including 845 cases of PE/E and 144 cases of SP . We randomly selected 989 normotensive pregnant women from the same period as controls (control group). Adjusted odds ratios and 95% confidence intervals for neonatal outcomes were calculated using logistic regression. Mediation analysis was conducted to investigate the role of GA in the relationship between HDP subtypes and preterm birth-related complications.
resultsBoth PE/E and SP increased the risk of adverse birth outcomes, including preterm birth, small for gestational age, low birth weight, and asphyxia, as well as hematological complications such as neutropenia, polycythemia, and thrombocytopenia. PE/E and SP also increased the risk of hypoglycemia while decreasing the risk of pathologic jaundice, with no impact on infection complications. Mediation analysis revealed that PE/E increased the risk of intraventricular hemorrhage while reducing the risk of patent ductus arteriosus and retinopathy of prematurity, both through direct effects (the disease of PE/E itself) and indirect effects (via GA). SP increased the risk of neonatal respiratory distress syndrome and intraventricular hemorrhage through indirect effects (via GA).
conclusionPE/E and SP are key maternal diseases influencing the outcomes of hospitalized neonates, with GA playing an important mediating role in preterm birth-related complications. Early monitoring and management of those mothers and infants are crucial to improving prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.